Somnomed finds UK distribution partner
Tuesday, 08 July, 2008
Somnomed [ASX: SOM] has appointed Intus Healthcare as the company's distribution partner for the UK market.
Intus will distribute Somnomed's dental Mandibular Advancement Splint (MAS) device for sleep apnea and snoring therapy device to the market.
The UK is generally considered to be one of the most important sleep therapy markets in Europe.
Intus is a major supplier of sleep therapy products, and is headquartered on the outskirts of London.
Defective sperm doubles pre-eclampsia risk in IVF patients
A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...
Free meningococcal B vaccines coming to the NT
The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine...
Mouth bacteria linked to increased head and neck cancer risk
More than a dozen bacterial species that live in people's mouths have been linked to a...
